Anti-GPRC5D CAR NK-cell therapy(KYinno Biotechnology)

N/A

Report date: 2024/06/20 14:46:44

Base Information

Drug NameAnti-GPRC5D CAR NK-cell therapy(KYinno Biotechnology)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy > Chimeric antigen receptor NK cell therapy
Mechanisms of ActionNatural killer cell replacementsG-protein coupled receptor family C group 5member D modulators
TargetsG-protein coupled receptor family C group 5member D
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesKYinno Biotechnology Co LtdCell Inspire Biotechnology
China Registration ClassN/A

Develop Information

Active CompaniesCell Inspire BiotechnologyKYinno Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A